IAImo J. Akpan

Imo J. Akpan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Imo J. Akpan has a total of 75 co-authors. Here are the top co-authors by number of shared publications:

  • Adam Korrick Lewkowitz

    Department of Obstetrics and Gynecology, Warren Alpert Medical School of Brown University, Providence, RI

    1 shared publication
  • Adamma Mba-Jonas

    Food and Drug Administration, Center for Biologics Evaluation and Research, Silver Spring, Maryland (E.J.W., A.M.)

    1 shared publication
  • Alexander Wei

    Columbia University Irving Medical Center

    1 shared publication
  • Ali Choaib

    23Department of Internal Medicine, Evidence-Based Practice and Impact Center, University of Kansas Medical Center, Kansas City, KS

    1 shared publication
  • Allison Lale

    Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta, Georgia (I.S., A.L., P.M., N.K.T., K.R.B., R.G., A.I.G., K.A.J., S.S., T.T.S., J.R.S., D.K.S.)

    1 shared publication
  • Allison P. Wheeler

    Division of Pediatric Hematology, Oncology, Bone Marrow Transplant, and Cellular Therapy, University of Washington, Seattle, WA

    1 shared publication

Latest Publications

  • American Society of Hematology 2026 guidelines for diagnosis of iron deficiency

    by Jacquelyn M. Powers, Ming Y. Lim, Maureen Okam Achebe, Imo J. Akpan, Michael Auerbach, Megan C. Brown, Maria Paula Cardenas, Caroline Cromwell, Thomas DeLoughery, Robert E. Fleming, et al.

    Background: Iron deficiency is the most common micronutrient deficiency and, when untreated, progresses to anemia. Existing guidance on the diagnostic criteria for iron deficiency is limited and not evidence based. Objective: These evidence-based guidelines of the American Society of Hematology (ASH) are intended to support patients, clinicians, and other health care professionals in their decisions about the diagnosis of iron deficiency, taking a global perspective in all settings. Methods: ASH established a multidisciplinary guideline panel that included 1 patient representative and was balanced to minimize potential bias from conflicts of interest. The University of Kansas Health System supported the guideline-development process, including performing systematic evidence reviews on the prevalence of iron deficiency across populations and studies to inform diagnostic thresholds up to July 2025. The panel prioritized clinical questions according to clinical impact and high-risk populations. The panel used the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach, including GRADE Evidence-to-Decision frameworks, to assess evidence and make recommendations, which were subsequently open for public comment. Results: The panel agreed on 5 recommendations. Conclusions: Key recommendations of these guidelines include serum ferritin thresholds for specific populations, with the goal to prioritize the diagnosis of iron deficiency, irrespective of the presence of anemia, remarks for considerations of other diagnostic thresholds, and guidance on the diagnosis of iron deficiency in persons with inflammation. Gaps in the literature and research priorities were also identified.


  • How I approach the prevention and treatment of thrombotic complications in hospitalized patients

    by Imo J. Akpan, Beverley J. Hunt

    This article uses case-based discussion to review prevention and management of thrombotic problems in hospitalized patients that involve a clinical hematologist. There is variation in the clinical hematologist’s role in thrombosis practice throughout the world, and we discuss this where indicated. Hospital-associated venous thromboembolism (VTE), or hospital-associated thrombosis (HAT), is the term to cover VTE occurring during admission and for 90 days postdischarge and is a common patient safety problem. HATs are the most common cause of VTE accounting for 55% to 60% of all VTE, with an estimated 10 million occurring globally. VTE risk assessment alongside evidence-based thromboprophylaxis reduces this risk significantly. Many hospitalized patients, especially older patients, use direct oral anticoagulants (DOACs), mainly to prevent stroke in atrial fibrillation. DOACs require perioperative management and may need urgent reversal. Other complex interventions such as extracorporeal membrane oxygenation which require anticoagulation are also discussed. Lastly, those with uncommon high-risk thrombophilias, especially those with antithrombin deficiency, produce unique challenges when hospitalized.


  • Open Access

    Neutrophil-erythrocyte rosettes suggestive of Coombs-negative autoimmune haemolysis

    by Jacob C Cogan, Pedro G Vianna, Imo J Akpan


  • Top Cited Papers

    Case Series of Thrombosis With Thrombocytopenia Syndrome After COVID-19 Vaccination—United States, December 2020 to August 2021

    by Isaac See, Allison Lale, Paige Marquez, Michael B. Streiff, Allison P. Wheeler, Naomi K. Tepper, Emily Jane Woo, Karen R. Broder, Kathryn M. Edwards, Ruth Gallego, et al.

    Using the Vaccine Adverse Event Reporting System, the number and demographic characteristics of cases of thrombosis with thrombocytopenia syndrome occurring after receipt of COVID-19 vaccines in th... Visual Thrombosis With Thrombocytopenia Syndrome After COVID-19 Vaccination. Using the Vaccine Adverse Event Reporting System, the number and demographic characteristics of cases of thromb... Background: Thrombosis with thrombocytopenia syndrome (TTS) is a potentially life-threatening condition associated with adenoviral-vectored COVID-19 vaccination. It presents similarly to spontaneou...


  • Open Access

    Biological and Clinical Factors contributing to the Metabolic Heterogeneity of Hospitalized Patients with and without COVID-19

    by Angelo D'Alessandro, Imo Akpan, Tiffany Thomas, Julie Reisz, Francesca Cendali, Fabia Gamboni, Travis Nemkov, Kiruphagaran Thangaraju, Upendra Katneni, Kenichi Tanaka, et al.

    The Corona Virus Disease 2019 (COVID-19) pandemic represents an ongoing worldwide challenge. Exploratory studies evaluating the impact of COVID-19 infection on the plasma metabolome have been performed, often with small numbers of patients, and with or without relevant control data; however, determining the impact of biological and clinical variables remains critical to understanding potential markers of disease severity and progression. The present large study, including relevant controls, sought to understand independent and overlapping metabolic features of samples from acutely ill patients (n = 831), testing positive (n = 543) or negative (n = 288) for COVID-19. High-throughput metabolomics analyses were complemented with antigen and enzymatic activity assays on 831 plasma samples from acutely ill patients while in the emergency department, at admission, and during hospitalization. We then performed additional lipidomics analyses of the 60 subjects with the lowest and highest body mass index, either COVID-19 positive or negative. Omics data were correlated to detailed data on patient characteristics and clinical laboratory assays measuring coagulation, hematology and chemistry analytes. Significant changes in arginine/proline/citrulline, tryptophan/indole/kynurenine, fatty acid and acyl-carnitine metabolism emerged as highly relevant markers of disease severity, progression and prognosis as a function of biological and clinical variables in these patients. Further, machine learning models were trained by entering all metabolomics and clinical data from half of the COVID-19 patient cohort and then tested on the other half yielding ~ 78% prediction accuracy. Finally, the extensive amount of information accumulated in this large, prospective, observational study provides a foundation for follow-up mechanistic studies and data sharing opportunities, which will advance our understanding of the characteristics of the plasma metabolism in COVID-19 and other acute critical illnesses.


  • Spontaneous remission in congenital leukemia

    by Jenna Rossoff, Imo Akpan, Leonidas C. Platanias

    (2018). Spontaneous remission in congenital leukemia. Leukemia & Lymphoma: Vol. 59, No. 10, pp. 2271-2272.